Skip to main content
hello world

BriaCell Therapeutics: Bottom 25 Performing Stocks Year-to-Date on TSX (BCT)

AI-generated - The Globe and Mail - Thu Feb 29, 4:46AM CST

BriaCell Therapeutics Corp is among the group of bottom performing stocks year-to-date on the Toronto Stock Exchange. This means each stock on this list has seen its share price decrease at a faster rate than the rest of the market so far this year.

This report is generated monthly. It highlights the 25 companies with the greatest percentage decrease in share price year-to-date. Stocks in this category are generally sold to preserve capital or held for speculation.

Companies experiencing dramatic increases in share price can do so for a variety of reasons – including bearish changes in sector outlook, or the company is experiencing financial difficulties generally due to an inability to service its debt.

SymbolNameTotal ReturnPeriod
GMTNGold Mountain Mining Corp-72.727273YTD
HZMHorizonte Minerals PLC-63.157895YTD
SSRMSSR Mining Inc-55.555556YTD
NCUNevada Copper Corp-50YTD
ELOEloro Resources Ltd-48.847926YTD
NUAGNew Pacific Metals Corp-48.207171YTD
ARArgonaut Gold Inc-47.87234YTD
NEXTNextSource Materials Inc-45YTD
BCTBriaCell Therapeutics Corp-41.410256YTD
EXROExro Technologies Inc-39.84375YTD
EGLXEnthusiast Gaming Holdings Inc-36.842105YTD
NGNovagold Resources Inc-35.151515YTD
ELREastern Platinum Ltd-35.135135YTD
ASCUArizona Sonoran Copper Co Inc-33.714286YTD
LSPDLightspeed Commerce Inc-33.537024YTD
MPCT-UNDream Impact Trust-33.441789YTD
RTGRTG Mining Inc-33.333333YTD
VRTSVertiqal Studios-33.333333YTD
FURYFury Gold Mines Ltd-32.835821YTD
SGLDSabre Gold Mines Corp-32.142857YTD
LAACLithium Americas (Argentina) Corp-31.976048YTD
SOLGSolGold PLC-31.428571YTD
TMLTreasury Metals Inc-31.428571YTD
ASNDAscendant Resources Inc-31.25YTD
ACBAurora Cannabis Inc-30.923077YTD

All data provided as of February 28, 2024.

More about BriaCell Therapeutics Corp

BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.

BriaCell Therapeutics Corp is listed under BCT on the Toronto Stock Exchange.

Artificial intelligence at Report on Business

Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.